Product Details
doi: 10.3389/fphar.2022.1026182 Received 23 August 2022 Accepted 23 November 2022 Published 14 December 2022 Volume 13 - 2022 Edited by Junmin Zhang, Lanzhou University, China Reviewed by Yurong Lai, Gilead, United States Mei-Hua Qu, Weifang Second Peoples Hospital, China Updates Copyright 2022 He, Feng, Guo, Zhou, Li, Zhang, Zhang, Wang, Wang, Hao, Zhang, Gao, Gu, Zhang, Li and Li
Many researchers transition between GLP-1 peptides
GLP-1 agonists like semaglutide and tirzepatide, used for weight loss
It also participates in the action of serotonin, a neurotransmitter known to control mood and appetite
Phase 1: Consultation and Assessment (Week 0) Comprehensive history and physical examination Review of prior imaging, surgical reports, and treatment history Discussion of goalsreturn to sport, pain reduction, GI symptom resolution, etc